Inclisiran for the treatment of hypercholesterolaemia: implications and unanswered questions from the ORION trials

Research output: Contribution to journalArticleAcademicpeer-review

33 Citations (Scopus)
Original languageEnglish
Pages (from-to)e136-e139
JournalCardiovascular research
Volume116
Issue number11
DOIs
Publication statusPublished - 1 Sept 2020

Keywords

  • ASGPR
  • Diabetes
  • Drug-delivery
  • GalNAc
  • Hypercholesterolaemia
  • Inclisiran
  • Inflammation
  • SiRNA

Cite this